Share this article Share this article NEW YORK, March 16, 2021 /PRNewswire/ -- OxyContin-maker Purdue Pharma filed today its Chapter 11 bankruptcy plan and disclosure statement before U.S. Bankruptcy Judge Robert Drain in New York. As anticipated, the funds allotted for the innocent infants and children swept up in the national opioid epidemic fell far short of ensuring that they receive critical health care, support, and monitoring during their early years. Purdue's bankruptcy plan allots $750 million to certain victim classes seeking damages for Purdue's history of opioid sales, including babies and children born suffering from opioid dependency adult victims, and other parties.